← Open Payments lookup

MEI KUEN ERICA TO: Open Payments

NPI 1114507506 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,668 in 157 payments from 40 companies in 2025. Trend: 2023 $691 · 2024 $6,735 · 2025 $5,668

Food & beverage: $5,074Long term medical supply or device loan: $399Education: $195
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$679
AstraZeneca Pharmaceuticals LP15$636
Janssen Biotech, Inc.10$595
Daiichi Sankyo Inc.20$515
Incyte Corporation8$273
ABBVIE INC.9$260
E.R. Squibb & Sons, L.L.C.2$259
Stemline Therapeutics Inc.5$216
Merck Sharp & Dohme LLC7$167
Eisai Inc.6$159

Products named: ENHERTU, KISQALI, RYBREVANT, JAKAFI, Orserdu, DATROWAY, REBLOZYL, Lenvima.

Industry payments across WA — which companies pay providers there.